The Effects of Dexmedetomidine on Cerebral Autoregulation and Cerebral Oxygenation in Subarachnoid Haemorrhage Patients
Phase of Trial: Phase I/II
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Aneurysm; Subarachnoid haemorrhage
- Focus Pharmacodynamics
- 03 Feb 2017 Status changed to completed.
- 28 Apr 2016 Planned primary completion date changed from 1 May 2016 to 1 Dec 2016.
- 23 Apr 2015 New trial record